Key statistics dashboard for Repligen Corporation (RGEN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.
Stock Data
| Price | $189.50 |
| Market Cap | $10.7B |
| Enterprise Value | $10.78B |
| Beta | 1.19 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 256.08 |
| Price / Book | 5.06 |
| P/S | 13.62 |
| EV/EBITDA | 88.47 |
| EV/Sales | 13.73 |
| EV/FCF | 97.30 |
| P/FCF | 96.54 |
| Earnings Yield | 0.39% |
| FCF Yield | 1.04% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 51.05% |
| EBIT Margin | 9.87% |
| EBITDA Margin | 15.52% |
| Operating Margin | 8.32% |
| Net Margin | 5.29% |
| Return on Equity | 1.98% |
| Return on Assets | 1.41% |
| Return on Invested Capital | 1.83% |
| Return on Capital Employed | 2.32% |
Financial Health
| Current Ratio | 9.05 |
| Quick Ratio | 7.64 |
| Cash Ratio | 4.57 |
| Debt / Equity | 0.33 |
| Debt / Assets | 23.42% |
| Net Debt / EBITDA | 0.69 |
| Interest Coverage | 2.95 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 7.49 |
Per-Share Data
| Revenue per share | 13.92 |
| Book Value per share | 37.46 |
| Cash per share | 14.37 |
| FCF per share | 1.96 |
| Tangible Book Value per share | 11.53 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 1 |
| Buy | 21 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 24 |
| Avg rating (1-5) | 0.96 |
Related companies: ATR · AVTR · BAX · BIO · CRL · DVA · GMED
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RGEN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks